Amarin Corp Plc (AMRN)

[alm2]

James- again not a chance in hell of that happening-there are no logical scientific or safety reason why approval should not be granted-conversely the evidence supporting approval is simply overwhelming -there is now an avalanche of evidence disseminating amongst the medical profession as to why they must prescribe V-labelling is the last obstacle - once the label is expanded Drs will have to prescribe or else they will breach their duty of care -they will face legal action for failure to prescribe
It is inevitable that the share price will increase on label approval as sales continue to rise and as takeover speculation develops - label approval will eliminate the principle obstacle to BO